Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2005-05-13
2011-11-01
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
Reexamination Certificate
active
08048439
ABSTRACT:
A therapeutic foam for the treatment of, inter alia, varicose veins comprises a sclerosing solution foamed with a physiological gas such as carbon dioxide, oxygen or a mixture thereof. The foam has a nitrogen content of less than 0.8%. It may be generated using a pressurized canister system incorporating a fine mesh of micron dimensions through which the gas and sclerosing liquid are passed to make the foam. Alternatively, the foam may be generated by passing gas and solution between two syringes through a fine mesh. Techniques are described for minimizing the amount of nitrogen in a canister or syringe based product. A technique for generating and delivering foam simultaneously using a syringe based device is also disclosed.
REFERENCES:
patent: 2630183 (1953-03-01), Foutz
patent: 2724383 (1955-11-01), Lockhart
patent: 3698453 (1972-10-01), Morane et al.
patent: 3767085 (1973-10-01), Cannon et al.
patent: 3955720 (1976-05-01), Malone
patent: 3970219 (1976-07-01), Spitzer et al.
patent: 4019657 (1977-04-01), Spitzer et al.
patent: 4040420 (1977-08-01), Speer
patent: 4127131 (1978-11-01), Vaillancourt
patent: 4276885 (1981-07-01), Tickner et al.
patent: 4292972 (1981-10-01), Pawelchak et al.
patent: 4328107 (1982-05-01), Wright
patent: 4466442 (1984-08-01), Hilmann et al.
patent: 4538920 (1985-09-01), Drake
patent: 4718433 (1988-01-01), Feinstein
patent: 5048750 (1991-09-01), Tobler
patent: 5064103 (1991-11-01), Bennett
patent: 5071379 (1991-12-01), Poizot
patent: 5084011 (1992-01-01), Grady
patent: 5141738 (1992-08-01), Rasor et al.
patent: 5368231 (1994-11-01), Brunerie
patent: 5425366 (1995-06-01), Reinhardt et al.
patent: 5425580 (1995-06-01), Belller
patent: 5454805 (1995-10-01), Brony
patent: 5542935 (1996-08-01), Unger et al.
patent: 5556610 (1996-09-01), Yan et al.
patent: 5623085 (1997-04-01), Gebhard et al.
patent: 5656200 (1997-08-01), Boettcher et al.
patent: 5676962 (1997-10-01), Cabrera-Garrido
patent: 5733572 (1998-03-01), Unger et al.
patent: 5902225 (1999-05-01), Monson
patent: 6053364 (2000-04-01), van der Heijden
patent: 6536629 (2003-03-01), van der Heijden
patent: 6561237 (2003-05-01), Brass et al.
patent: 6572873 (2003-06-01), Osman et al.
patent: 6605066 (2003-08-01), Gravagna et al.
patent: 6942165 (2005-09-01), Osman et al.
patent: RE38919 (2005-12-01), Garrido et al.
patent: 7025290 (2006-04-01), Osman et al.
patent: 7357336 (2008-04-01), Osman et al.
patent: 2002/0031476 (2002-03-01), Trevino et al.
patent: 2002/0056730 (2002-05-01), van der Heijden
patent: 2002/0077589 (2002-06-01), Tessari
patent: 2002/0101785 (2002-08-01), Edwards et al.
patent: 2004/0156915 (2004-08-01), Harman et al.
patent: 2005/0002873 (2005-01-01), Harman et al.
patent: 2006/0049269 (2006-03-01), Osman et al.
patent: 2006/0062736 (2006-03-01), Wright et al.
patent: 2006/0280690 (2006-12-01), Wright et al.
patent: 2007/0003488 (2007-01-01), Wright et al.
patent: 2007/0003489 (2007-01-01), Wright et al.
patent: 2007/0031345 (2007-02-01), Harman et al.
patent: 2007/0031346 (2007-02-01), Harman et al.
patent: 2007/0104651 (2007-05-01), Wright et al.
patent: 2008/0145401 (2008-06-01), Osman et al.
patent: 2008/0274060 (2008-11-01), Wright et al.
patent: 1 232 837 (1988-02-01), None
patent: 26 08 771 (1976-09-01), None
patent: 3048744 (1982-07-01), None
patent: 3050812 (1985-03-01), None
patent: 8704600.8 (1987-11-01), None
patent: 3417182 (1989-01-01), None
patent: 00 11 381 (1980-05-01), None
patent: 0 054 728 (1982-01-01), None
patent: 0 077 752 (1983-04-01), None
patent: 0 13 235 (1984-10-01), None
patent: 0 131 540 (1985-01-01), None
patent: 0 217 582 (1987-04-01), None
patent: 0 324 938 (1989-07-01), None
patent: 0 359 246 (1990-03-01), None
patent: 0564505 (1993-10-01), None
patent: 0586875 (1994-03-01), None
patent: 06 13 836 (1994-09-01), None
patent: 0 656 203 (1995-06-01), None
patent: 0 997 396 (2000-05-01), None
patent: 1716871 (2006-02-01), None
patent: 2 068 151 (1995-04-01), None
patent: 1 547 768 (1969-11-01), None
patent: 2 672 038 (1992-07-01), None
patent: 2 775 436 (1999-09-01), None
patent: 2369996 (2002-06-01), None
patent: 10081895 (1998-03-01), None
patent: H8-235664 (1998-03-01), None
patent: H10-81895 (1998-03-01), None
patent: WO92/05806 (1992-04-01), None
patent: WO 92/11873 (1992-07-01), None
patent: WO 93/05819 (1993-04-01), None
patent: WO 94/21384 (1994-09-01), None
patent: WO95/00120 (1995-01-01), None
patent: WO 95/00120 (1995-01-01), None
patent: WO 96/08227 (1996-03-01), None
patent: WO96/25194 (1996-08-01), None
patent: WO 96/38180 (1996-12-01), None
patent: WO 97/13585 (1997-04-01), None
patent: WO99/43371 (1999-09-01), None
patent: WO00/24649 (2000-05-01), None
patent: WO 00/72821 (2000-05-01), None
patent: WO00/66274 (2000-11-01), None
patent: WO00/72821 (2000-12-01), None
patent: WO 00/78629 (2000-12-01), None
patent: WO 02/058834 (2002-08-01), None
patent: WO 03/013475 (2003-02-01), None
patent: WO 2004/047969 (2004-06-01), None
patent: WO 2005/115484 (2005-08-01), None
Cabrera, Juan, “Echo-Sclerotherapy of Long Saphenous Veins and Venous Malformations With Sclerosing Agents in Microfoam Long-Term Outcomes,” A Joint meeting of the Canadian Society of Phlebology and The Sclerotherapy Society of Australia, The Transpacific Phlebology Forum, 112, Jun. 27-Jul. 1, 1997, Australia.
Cabrera, J., “Sclerosants in Microfoam,” International Angiology, 2001, 322-329.
Cabrera, J., “Treatment of Venous Malformations with Sclerosant in Microfoam Form,” Arch Dermatol, vol. 139, 2003, 1409-1416.
Frullini, A., “New Technique in Producing Sclerosing Foam in a Disposable Syringe,” Dermatol Surg, 2000, 26, 705-706.
Henriet, J.P. “One Year of Daily Application of Sclerotherapy (Reticular Veins and Telangiectases) Using Polidocanol Foam: Feasibility, Results, Complications,” Phlebologie, 1997, 50, No. 3, 355-360, Britain.
Monfreux, A., “Sclerosant Treatment of Saphenous Truncs and Their Large Calibre Collaterals by the MUS Method,” Phlebologie, 1997, 50, No. 3, 351-353.
Tessari, L., “New Technique for Obtaining Sclero-Foam,” Phlebologie, 2000, 53, No. 1, 129.
Tessari, L., “Preliminary Experience with a new Sclerosing Foam in the Treatment of Varicose Veins,” Dermatol surg, 2001, 27, 58-60.
Judgment dated May 22, 2007, in German Nullity Appeal Proceedings BTG International Ltd., X ZR 56/03.
Communication from the Examining Division of the European Patent Office in EP04798564, dated Apr. 26, 2007.
Reply to Communication from the Examining Division of the European Patent Office in EP04798564, dated Jan. 18, 2008.
Office Action dated Sep. 3, 2009, in co-pending U.S. Appl. No. 11/914,192.
“The F2 Finger Pump Foamer,” Airspray.
Cabrera-Garrido, et al., “New Sclerosing Products: Extending limits in Sclerotherapy,” Phlebologie, 50 No. 2, p. 181-188, 1997.
Minga, Javier Garcia, “Venous sclerotherapy with foam: ‘Foam Medical System’,” p. 1-3, 1999.
Garrido, Jesús, “Medicine: Microfoam sclerosants against venous illnesses,” Medical News, p. 12-16, May 1997.
Baniel, A. et al., “Foaming Properties of Egg Albumen with a Bubbling Apparatus compared with Whipping,” J. Food Science, vol. 62(2): 377-381, 1997.
Eurospray—Examples of refillable air powered containers.
Eurospray—Pictures of Eurospray devices, No. 1.
Eurospray—Pictures of Eurospray devices, No. 2.
Eurospray—Pictures of Eurospray devices, No. 3.
Eurospray—Pictures of Eurospray devices, No. 4.
Eurospray—Pictures of Eurospray devices, No. 5.
Eurospray—Pictures of Eurospray devices, No. 6.
Eurospray—Pictures of Eurospray devices, No. 7.
Eurospray—Pictures of Eurospray devices, No. 8.
Eurospray—Pictures of Eurospray devices, No. 9.
Eurospray—Pictures of Eurospray devices, No. 10.
British Technology Group, Leaflet on Atmosol—“The Atmosol Regulator,” The Atmosol System.
British Technology Group, Leaflet on Atmosol—The Accept
Harman Anthony David
Hodges Garry
Jenkins William John
Kadar Adil
Moggridge Geoffrey D.
BTG International Ltd.
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Holt Andriae M
Richter Johann
LandOfFree
Therapeutic foam does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic foam, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic foam will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4291808